Brigham and Women's Hospital investigators link very high lipoprotein(a) with a higher 30-year risk of major cardiovascular ...

Find out how lipoprotein(a) screening identifies women at long term cardiovascular risk and supports earlier prevention ...

Currently available therapies such as niacin and PCSK9 inhibitors such as Repatha (evolocumab) and Praluent (alirocumab) can reduce Lp (a) levels, but their impact is modest. Another challenge in ...

Comparing extremes of the spectrum, multivariable analyses generally showed significantly higher risks for patients with high ...

Every Australian adult should be screened for a potentially deadly type of inherited cholesterol, and if the simple blood ...

Dennis R. Leahy, MD, shares his POV on the value of making Lp(a) testing universal, not only to inform patients and their clinicians of the high CV risks, but to make way for potential treatments.

Fast-growing commercial-stage diagnostics company numares AG today announced the worldwide launch of its new, software-based test insightLP™-S50, part of the Company’s lipoFIT® series for lipoprotein ...

NEW YORK--(BUSINESS WIRE)--LetsGetChecked, a global healthcare solutions company, today announced its collaboration with Novartis to increase access to Lipoprotein(a)–Lp(a)–testing and programs. Now, ...

A study finds that a blood test that evaluates levels of three compounds — lipoprotein(a), C-reactive protein (a marker of inflammation), and “bad” LDL cholesterol — can accurately reveal heart ...

When C. Michael Gibson of Boston saw his doctor in the spring of 2023, the blood test results were confusing. His cholesterol levels were decent — he was already taking statins to keep the “bad” ...